共 29 条
Impact of intraoperative goal-directed fluid therapy on major morbidity and mortality after transthoracic oesophagectomy: a multicentre, randomised controlled trial
被引:52
作者:
Mukai, Akira
[1
]
Suehiro, Koichi
[1
]
Watanabe, Ryota
[2
]
Juri, Takashi
[1
]
Hayashi, Yasue
[3
]
Tanaka, Katsuaki
[1
]
Fujii, Takashi
[4
]
Ohira, Naoko
[3
]
Oda, Yutaka
[5
]
Okutani, Ryu
[2
]
Nishikawa, Kiyonobu
[1
]
机构:
[1] Osaka City Univ, Dept Anaesthesiol, Grad Sch Med, Osaka, Osaka, Japan
[2] Osaka City Gen Hosp, Dept Anaesthesiol, Osaka, Osaka, Japan
[3] Sumitomo Hosp, Dept Anaesthesiol, Osaka, Osaka, Japan
[4] Osaka Rosai Hosp, Dept Cardiovasc Anaesthesiol, Sakai, Osaka, Japan
[5] Osaka City Juso Hosp, Dept Anaesthesiol, Osaka, Osaka, Japan
关键词:
goal-directed therapy;
haemodynamic monitoring;
morbidity;
mortality;
multicentre randomised controlled trial;
postoperative;
transthoracic oesophagectomy;
stroke volume;
stroke volume variation;
STROKE VOLUME VARIATION;
PULSE PRESSURE VARIATION;
RESPONSIVENESS;
SURGERY;
PREDICTORS;
COMPLICATIONS;
MANAGEMENT;
RECOVERY;
SOCIETY;
CANCER;
D O I:
10.1016/j.bja.2020.08.060
中图分类号:
R614 [麻醉学];
学科分类号:
100217 ;
摘要:
Background: Transthoracic oesophagectomy is associated with major morbidity and mortality, which may be reduced by goal-directed therapy (GDT). The aim of this multicentre, RCT was to evaluate the impact of intraoperative GDT on major morbidity and mortality in patients undergoing transthoracic oesophagectomy. Methods: Adult patients undergoing transthoracic oesophagectomy were randomised to receive either minimally invasive intraoperative GDT (stroke volume variation <8%, plus systolic BP maintained >90 mm Hg by pressors as necessary) or haemodynamic management left to the discretion of attending senior anaesthetists (control group; systolic BP >90 mm Hg alone). The primary outcome was the incidence of death or major complications (reoperation for bleeding, anastomotic leakage, pneumonia, reintubation, >48 h ventilation). A Cox proportional hazard model was used to examine whether the effects of GDT on morbidity and mortality were independent of other potential confounders. Results: A total of 232 patients (80.6% male; age range: 36-83 yr) were randomised to either GDT (n=115) or to the control group (n=117). After surgery, major morbidity and mortality were less frequent in 22/115 (19.1%) subjects randomised to GDT, compared with 41/117 (35.0%) subjects assigned to the control group {absolute risk reduction: 15.9% (95% confidence interval [CI]: 4.7-27.2%); P=0.006}. GDT was also associated with fewer episodes of atrial fibrillation (odds ratio [OR]: 0.18 [95% CI: 0.05-0.65]), respiratory failure (OR: 0.27 [95% CI: 0.09-0.83]), use of mini-tracheotomy (OR: 0.29 [95% CI: 0.10-0.81]), and readmission to ICU (OR: 0.09 [95% CI: 0.01-0.67]). GDT was independently associated with morbidity and mortality (hazard ratio: 0.51 [95% CI: 0.30-0.87]; P=0.013). Conclusions: Intraoperative GDT may reduce major morbidity and mortality, and shorten hospital stay, after transthoracic oesophagectomy.
引用
收藏
页码:953 / 961
页数:9
相关论文